Transcript Highlights:

• Many rare diseases do not have FDA-approved treatments, and most rare diseases are genetic in nature.
• Is it based on genetic information and the ability to take advantage of that now?
• Right, and it's based on your own genetic information.
• It's not like we're trying to allow the law to take somebody else's genetic information and make your
• This is for those that have a genetic component that are rare in orphan diseases.

Bills: HB216

Keywords: HB216, Texas abortion law, abortion-inducing drug, medication abortion, mifepristone, misoprostol, telemedicine, in-person exam, physician presence, out-of-state physician, reproductive healthcare, abortion regulation, Health and Safety Code, Occupations Code, consultation services, remote prescribing, pro-life, pro-choice

Summary: The Committee on Public Health met with a quorum and heard public testimony on a long agenda, with members repeatedly reminded of a two-minute limit for witnesses. Several bills were voted out favorably, including HB 2588 on cottage food, HB 1639 on cancer incidence and female firefighters, HB 2581 on a reporting form for contracted services for pregnant women, and SB 922 on electronic disclosure of certain sensitive medical information. Those measures generally passed on party-line or near-unanimous votes, while HB 216 on itemized medical statements was left pending after the committee substitute was withdrawn. The committee also left pending HB 5141, HB 4638, HB 2035, HB 4813, HB 2264, HB 4014, and HB 3829 after hearing testimony and questions. The final item introduced in the excerpt was HB 4408 on health care market transparency and corporate consolidation, but the discussion was cut off before testimony or action was completed. A major theme of the hearing was mental health diversion and access to treatment. HB 5141, by Rep. Howard, would allow Travis County to use vacated Austin State Hospital property for a local mental health jail diversion center; law enforcement, the Travis County sheriff, county judge, and urban counties group all testified in support, describing the lack of alternatives for people in crisis and the burden on jails and emergency rooms. Members asked about eligible offenses, bed capacity, and whether the facility would serve only Travis County, and the bill was left pending. HB 2264, by Rep. Schoolcraft, would create a friends-and-family form for loved ones to provide information to providers during emergency mental health treatment; NAMI and hospital groups supported it, while one neutral witness and several members raised concerns about patient control, credibility of information, and liability protections. The bill was also left pending. The committee also heard multiple psychedelic-therapy and drug-policy bills. HB 4813 would speed Texas rescheduling of Schedule I substances if the FDA reclassifies them, with testimony focused on psilocybin and MDMA and their potential use for PTSD and depression; members questioned whether the bill was too broad and how state rescheduling works, and it was left pending. HB 4014 would direct HHSC to study psychedelic therapies, building on prior state research, and witnesses said Texas should prepare regulatory and clinical infrastructure before FDA approval; it too was left pending. HB 2035 would require parents to be informed that they may seek substance-use treatment for a child even if one facility turns them away, prompted by a constituent’s account of a fatal fentanyl overdose after receiving incorrect advice; it was left pending. HB 4638 would extend and expand the Texas Pharmaceutical Initiative board and timeline, with the author saying the program is still in early implementation and needs more time, and it was left pending as well. Other bills addressed public health administration and animal welfare. HB 3829 would require a study of the animal-friendly account and its grant process for spay/neuter funding, with the author arguing that the current application and reimbursement process is too burdensome for shelters and nonprofits; no opposition was heard and the bill was left pending. HB 2581 and HB 1639 were reported favorably, while HB 216 drew discussion about enforcement of itemized medical billing and was held after the committee substitute was withdrawn. Throughout the hearing, members also discussed broader concerns about homelessness, competency restoration waitlists, jail overcrowding, and the need for more treatment options outside the criminal justice system.

Transcript Highlights:

• that’s very similar in the sheep and goat family, and we’ve eradicated scrapie basically by just genetics
• c> we're<01:02:47.760> breeding<01:02:48.240> for<01:02:49.000> animals genetics
• and we're breeding for animals genetics and we're breeding for animals that<01:02:49.440> don't
• <01:35:30.400> resistant farms can now release genetic resistant farms can now release genetic
• <01:37:00.520> resistance important we do have genetic resistance important we do have genetic

Keywords: 1187, senate, all

Transcript Highlights:

• And I mentioned in the previous panel work with genetically modified organisms and gene drive.
• are screening those flies to make sure that the wild female has to be willing to mate with that genetically
• The big benefit of using the sterilization process is that often when we release a genetically modified
• But because these are sterilized flies, they're not going to be passing their genetics on to another
• Now, we have had several genetically modified organisms released into... ...genetically modified organisms

Summary: The joint hearing focused on preparedness for the New World screwworm threat and brought together the House Committees on Culture, Recreation, and Tourism and Agriculture and Livestock. USDA officials, Texas Department of Agriculture Commissioner Sid Miller, and Texas Animal Health Commission leadership described the pest as a serious risk to livestock, wildlife, rural economies, and beef prices, and emphasized coordination among federal, state, industry, and Mexican partners. Witnesses repeatedly stressed that Texas is currently seeing no confirmed U.S. detections, but that recent confirmed cases in northern Mexico, including Nuevo León, remain a concern because of their proximity to the border. USDA testimony outlined current surveillance and response efforts, including more than 120 screw worm-specific traps along the Texas border and neighboring states, thousands of additional dual-purpose traps, wildlife inspections, weekly coordination with Mexico’s Senasica, and a new USDA New World Screwworm Directorate. Officials said the existing Panama sterile fly facility is maxed out at about 100 million flies per week, while a dispersal facility in Tampico is helping move flies farther north in Mexico. They also described plans for a retrofitted sterile fly facility in Metapa, Mexico, expected to come online in 2026, and a new domestic production facility at Moore Air Base, with phase one targeted for late 2026 or early 2027 and phase two adding substantially more capacity later. Members pressed USDA on timelines, production capacity, the reliability of Mexican reporting, the risk from wildlife, and whether modular or mobile facilities could be deployed faster. USDA said it is also exploring innovative technologies, including a genetically engineered sterile male fly, but that such tools still require EPA review and field validation. Commissioner Miller highlighted Texas biosecurity efforts, five permanent inspection stations, cooperation with FDA and EPA on treatments such as Exzolt, and other pest issues affecting Texas agriculture. He also noted research into fly bait and private-sector efforts to speed sterile fly production. Texas Animal Health Commission officials described extensive state preparedness work, including weekly coordination calls, field response trainings, outreach to producers and veterinarians, and a Texas Screwworm Response Team. They said Texas has trained more than 100 inspectors and other personnel, with additional trainings planned, and that the state is expanding its cattle fever tick rider program. No votes or formal committee actions were taken during the hearing; the main action was the exchange of testimony and questions about readiness, surveillance, and facility timelines.

Transcript Highlights:

• What this bill does is it pauses the removals for three years so that we can do a genetic diversity study
• What this bill does is it allows for the genetic diversity studies to take place, protects the herd for
• three years, and doesn't allow genetic diversity studies to take place, protects the herd for three
• years, and doesn't allow for removals during the time that the genetic diversity study is taking place

Summary: The House met, opened with prayer and the Pledge, approved the prior journal, and first took up a motion to request Senate consent for an extended adjournment. Representative Volk opposed the motion, arguing members should keep working on unfinished business, while Speaker Montenegro said the House had completed its current budget work and was waiting on the governor to return to negotiations. The motion passed 31-20, and the House also agreed to a related Senate adjournment request and to return HB 2415 to the Senate for reconsideration. The chamber then went into Committee of the Whole and considered several Senate bills. SB 1199, concerning the Salt River wild horse herd, was amended to pause removals for a genetic diversity study and received a do-pass recommendation. SB 1399 on Medicaid spending transparency, SB 1496, SB 1497, SB 1582, SB 1713, and SB 1798 were also amended and advanced. SB 1713 drew the most debate, with supporters saying it would expand pharmacist access to basic care and improve rural and veteran access, while opponents warned it expanded scope of practice beyond pharmacists’ training. The House later adopted the Committee of the Whole report, ordered several bills engrossed, and sent SB 1399 to third reading. In a second Committee of the Whole, SB 1214 and SB 1670 were further amended and advanced. The House then moved to third reading and voted on multiple bills. SB 1006, SB 1037, SB 1171, SB 1242, SB 1270, SB 1419, SB 1429, SB 1445, SB 1452, SB 1478, and SB 1566 passed, while SB 1099 and SB 1635 failed on the initial vote. Members then used reconsideration motions to place SB 1006 and SB 1635 back on the third-reading calendar. The session ended with personal privilege remarks recognizing correctional officers, Cinco de Mayo guests, Missing and Murdered Indigenous Peoples Awareness Day, and other tributes, followed by adjournment until June 1, 2026.

Transcript Highlights:

• It's sometimes covered for cancer or people transitioning, but for premature ovarian failure due to genetics
• The genetic illness uniquely affects primarily Black and Brown people, as we've said, and although sickle
• As we were entering the molecular age that we are currently in, it was the discoveries, the genetic basis
• of sickle cell, that allowed us to learn what all of our genetics are doing.
• And for us... ...that allowed us to learn what all of our genetics are doing and for us to be able to

Keywords: 995, all

Summary: The hearing opened with the Senate and House chairs of the Joint Committee on Financial Services explaining that the day’s agenda would focus on health insurance and other insurance matters, with a large number of witnesses and a request for brief testimony. Legislators were taken out of order to accommodate their schedules, and the committee heard testimony on several bills, including coverage for hair prostheses for alopecia (H. 1223/S. 832), medically necessary oral and dental care for head and neck cancer survivors (H. 1258), modernizing fertility and family-building coverage (H. 715/H. 1190 and related bills), coverage for prosthetic devices to support physical activity for people with limb loss (the “So Everybody Can Move” bill), remediation coverage for home heating oil releases (S. 813/H. 1302), and expanded access to physical therapy for Ehlers-Danlos syndrome (H. 1170). A separate bill on sickle cell care and registry development (S. 788) was also discussed by Senator Liz Miranda. Witnesses largely offered personal stories and expert testimony in support of the bills. Advocates for alopecia coverage described the medical and emotional impact of hair loss, the high cost of quality wigs, and the argument that scalp and facial hair prostheses should be treated like other medically necessary prosthetics. Cancer survivors and supporters of H. 1258 said oral and dental care after head and neck cancer treatment is a quality-of-life issue and often not covered despite major out-of-pocket costs. Fertility specialists, LGBTQ+ advocates, and legislators supporting the modern family-building bills said the current infertility definition is outdated and discriminatory, excluding same-sex couples, people needing donors or gestational carriers, and others with medical barriers to conception. For the limb-loss bill, parents and adults with prosthetic needs stressed that activity-specific prostheses are essential for children and adults to run, swim, play sports, and stay healthy, but are often excluded from coverage. The home heating oil testimony focused on the financial devastation caused by residential oil spills and the need to make spill coverage automatic in homeowners policies. Environmental professionals and homeowners described cleanup costs ranging from tens of thousands to hundreds of thousands of dollars, the strict liability homeowners face, and the fact that many policyholders do not know the rider exists. The insurance industry testified in opposition to the mandatory-coverage approach, arguing for clearer distinctions between first- and third-party coverage, risk-mitigation standards, a delayed effective date, and more emphasis on education and notification rather than mandates. Committee members pressed the industry witness on why agents do not routinely tell customers about the rider and suggested that the issue may require broader disclosure by insurers, agents, and fuel dealers. No votes were taken during the hearing; the committee heard testimony and discussed possible compromise language and future action.

Transcript Highlights:

• What this bill does is it pauses the removals for three years so that we can do a genetic diversity study
• What this bill does is it allows for the genetic diversity studies to take place, protects the herd for
• three years, and does not allow genetic diversity studies to take place, protects the herd for three
• years, and does not allow for removals during the time that the genetic diversity study is taking place

Keywords: 1182, all

Transcript Highlights:

• Tim Tubman, licensed genetic molecular biologist, scientist, and incoming president of the California
• Tim Tubman, licensed genetic molecular biologist, scientist, and incoming president of the California
• Tim Tubman, licensed genetic molecular biologist, scientist, and incoming president of the California
• Missy Johnson with Nielsen-Merksemer, here on behalf of Myriad Genetics, in support.

Summary: The Assembly Business and Professions Committee held its first regular bill hearing of 2025 and considered a wide range of measures on health care access, professional regulation, animal welfare, and consumer protection. Early in the hearing, the committee adopted its rules and then approved a consent calendar of several bills, including measures by Chen, Caloza, Carrillo, Arreguín, Berman, and Flora. The committee also took up AB 1082, which would allow California nursing students enrolled in out-of-state programs to complete clinical training in California; supporters said it would help address the nursing shortage and keep students closer to home, while opponents warned it could worsen already limited clinical placement capacity and reduce oversight. The bill passed on a do pass recommendation to Appropriations after a quorum was established. The committee then heard and advanced several health-related bills. AB 50, by Assembly Member Bonta, would ease Medi-Cal access to over-the-counter hormonal contraception by removing the need for a prescription for coverage purposes; pharmacists, reproductive health advocates, and medical groups supported the bill, and it passed unanimously to the Committee on Health. AB 489, also by Bonta, would prohibit AI systems from misrepresenting themselves as licensed health professionals; supporters from medical, psychiatric, behavioral health, and other professional groups said the bill would protect patients from misleading chatbot advice, and it passed to Privacy and Consumer Protection. AB 481, by Assembly Member Rubio, would expand the tasks that federally qualified lab personnel can perform under CLIA supervision to help address lab staffing shortages; labor groups raised concerns about training, certification, and supervision, but the bill passed to Appropriations with an amended do pass recommendation. The committee also considered animal welfare and access-to-care measures. AB 631, by Assembly Member Lee, would require animal shelters to post intake and outcome data online; supporters said the reporting would improve policy and resource allocation, while members discussed how the requirement would work for shelters without websites, and the bill passed to Appropriations. AB 867, also by Lee, would prohibit cat declawing except when medically necessary for the animal; animal welfare groups strongly supported the bill, while the veterinary association opposed it as an improper legislative regulation of veterinary surgery, and the bill passed to Appropriations. Finally, AB 1307 would create a pilot program allowing a limited number of qualified dentists trained in Mexico to practice in underserved California areas; supporters framed it as a cost-neutral way to address major dental access gaps, the California Dental Association remained opposed unless amended, and the bill passed to Appropriations. Several members later added their votes on the various items after the hearing, and the committee kept the hearing open briefly to allow additional add-ons.

Transcript Highlights:

• Because they're genetically identical, there would be no way to tell which of those individuals did..
• specific intent to result in the gestation or birth of a child. in the gestation or birth of a child genetically
• But really, what this does is create a criminal penalty if you were to access and use someone's genetic

Bills: SB210, SB176, SB167, SB244, SB218, SB9, SB153, SB9

Keywords: hospital liens, medical billing, government healthcare, insurance claims, patient rights, controlled substances, unlawful distribution, marijuana, violent offense, sentencing guidelines, criminal justice, aggravated theft, employee benefits, retirement funds, criminal penalty, state law, overdose, failure to render aid, public health, Alabama Athletic Commission

Transcript Highlights:

• <00:43:11.119> disorders<00:43:12.119> this life-threatening genetic disorders this
• life-threatening genetic disorders this funding<00:43:12.599> has<00:43:12.760> enabled
• So the opportunity to develop genetically modified approaches where we can insert adult stem cells, for
• <00:46:39.359> modified to develop um genetically modified to develop um genetically modified
• and then um reprogrammed genetically and then um reintroduced<00:46:51.000> in<00:46:51.119><

Keywords: 1183, house

Transcript Highlights:

• She said 72% are genetic diseases and 70% start in childhood. more um data on what's going on um Dr more
• She said her child's genetic disease showed up at birth, but it took until age 14 to get a diagnosis.
• disease showed up child yes her genetic disease showed up at<01:06:25.359> BIR at BIR at BIR
• but also getting um access to genetic but also getting um access to genetic counselors<01:06:59.640
• to about that Family who was a genetic to about that Family who was a genetic predisposition<04:

Keywords: 1189, house, all

Transcript Highlights:

• have a direct flight from Honolulu to Majuro, there was concern that the beetle came from Oahu, but genetic
• have a direct flight from Honolulu to Majuro, there was concern that the beetle came from Oahu, but genetic
• have a direct flight from Honolulu to Majuro, there was concern that the beetle came from Oahu, but genetic
• That the beetle came from Oahu, but genetic tests suggest that it did not.
• against Beatles that are genetically against Beatles that are genetically similar<02:21:28.760><

Keywords: 910, house, all

Summary: The joint House and Senate agriculture committees met on January 17, 2025, for an informational briefing on biosecurity and invasive species; Chair Kahaloa opened by noting there would be no public testimony. Members introduced themselves, and the Hawaiʻi Invasive Species Council (HISC) program manager Chelsea Arnot outlined the purpose of the briefing and the statewide impacts of invasive species, citing examples such as coconut rhinoceros beetle, little fire ant, coquí frogs, albizia, and mosquito-borne disease. She emphasized that biosecurity requires coordinated action across state departments, counties, federal agencies, universities, and communities, and highlighted HISC’s role in funding interagency projects, island invasive species committees, research, outreach, and early detection efforts. Arnot and HISC representatives described major funding and program needs, including a requested $4.25 million increase to HISC to raise its baseline budget to $10 million, support island committee operations, research, biocontrol, marine biosecurity, surveillance, and staffing. They also requested $500,000 for the Hawaiʻi Ant Lab, saying it is critical to invasive ant research and little fire ant response. The briefing also noted HISC’s leverage of federal dollars, including a $4.6 million REPI award with HISC providing the match, and cited successful collaborative eradications and responses, including veiled chameleons on Maui, axis deer on Hawaiʻi Island, and a 2023 coconut rhinoceros beetle response on Maui that prevented further spread. Hawaiʻi Department of Agriculture officials then discussed implementation of updated administrative rules effective January 20, 2025, which permanently restrict movement of coconut rhinoceros beetle host material and give the department stronger authority to stop movement of infested material. They reported 2024 import activity of about 50,000 ship and aircraft arrivals, inspection/clearance of 20 million pieces, and 16,000 interceptions, with additional staffing from Act 231 expected to increase interceptions. They also described Act 231 funding and current spending status: about 65% obligated and 52% encumbered, with some funds tied to contracts for CRB and little fire ant response, plus an $800,000 green-waste hauling RFP that had to be reissued because of a flaw. The department said 580 Oʻahu homes and 290 Hawaiʻi Island homes are slated for little fire ant treatment, while Maui and Kauaʻi will focus on survey and outreach. Members questioned how homes are selected for subsidized treatment, whether HISC and the island invasive species committees received Act 231 support, and whether the state should direct how contracted funds are prioritized. Representative Martin raised concerns that the RFP limited eligibility to private pest control companies and excluded more experienced entities such as the Hawaiʻi Ant Lab. Department officials said they would follow up on prioritization and funding details, and noted that emergency proclamations and procurement flexibility could help with rapid response and hiring during invasive species emergencies.

Transcript Highlights:

• Senate File 2077, Senator Her, the Environment, Natural Resources Appropriations, and Provisions Modifications
• Senate File 2077, Senator Her, the Environment, Natural Resources Appropriations, and Provisions Modifications
• you for recognizing the importance of this grain, of this lifegiving, um, you know, it's almost a genetic
• <02:23:46.240> a lifegiving um you know it's almost a lifegiving um you know it's almost a genetic
• <02:23:48.000> uh genetic uh genetic uh uh<02:23:50.399> value<02:23:50.800> within<

Keywords: 1187, senate, all

Transcript Highlights:

• The study also investigates cervid genetic resistance. to CWD using genotype analysis to explore whether
• And then also, there are some individuals out there that are doing genetic genotyping who believe they

Bills: SB2031, SB2386, SB2476, SB2801, SB2843, SB2844, SB2846, SB2885

Keywords: deer breeding, chronic wasting disease, wildlife management, release site, landowner rights, TCEQ, environmental quality, administrative actions, public notice, legislative oversight, water supply, Angelina and Neches River Authority, ownership transfer, public utilities, Certificate of Convenience and Necessity, SB 2801, Texas Parks and Wildlife, Parks and Wildlife Code, field trial permit, hunting dog field trial

Transcript Highlights:

• Derived data, genetic data, identified or identifiable genetic data, identified or identifiable individual
• transgender, citizenship or immigration status, mental or physical health condition, consumer health data, genetic

Keywords: 927, senate, all

Transcript Highlights:

• For those of you who don't know, sickle cell is a genetic condition that causes some of an affected person's
• You've got a genetic disorder.
• A genetic charge, a genetic disease that affects so many, but do we really have our arms around the breadth

Bills: SCR 13, SCR 24, SB 1, SB 12, SB 15, SB 17, SB 24, SB 57, SB 65, SB 213, SB 371, SB 372, SB 378, SB 379, SB 388, SB 400, SB 402, SB 427, SB 495, SB 499, SB 502, SB 509, SB 535, SB 583, SB 610, SB 621, SB 650, SB 706, SB 740, SB 840, SB 854, SB 856, SB 875, SB 893, SB 918, SB 925, SB 974, SB 995, SB 1006, SB 1018, SB 1025, SB 1061, SB 1073, SB 1106, SB 1121, SB 1194, SB 1252, SB 1253, SB 1268, SB 1300, SB 1343, SB 1362, SB 1447, SJR 36, SJR 12, SJR 57, SCR 25, SCR 22, SCR 12, SCR 24, SCR 8, SB 565, SB 372, SB 765, SB 62, SB 666, SB 707, SB 888, SB 687, SB 847, SB 1248, SB 740, SB 14, SB 1006, SB 504, SB 925, SB 1121, SB 995, SB 857, SB 305, SB 296, SB 284, SB 815, SB 1379, SB 1300, SB 1497, SB 1499, SB 1498, SB 1061, SB 65, SB 241, SB 304, SB 402, SB 499, SB 621, SB 974, SB 1023, SB 1024, SB 1025, SB 1106, SB 686, SB 112, SB 371, SB 204, SB 400, SB 609, SB 1447, SB 670, SB 502, SB 427, SB 850, SB 854, SB 413, SB 1555, SB 1362, SB 1346, SB 1033, SB 1220, SB 1073, SB 810, SB 987, SB 1539, SB 893, SB 447, SB 875, SB 406, SB 509, SB 985, SB 965, SB 1119, SB 1505, SB 24, SB 57, SB 1194, SB 1253, SB 1215, SB 1532, SB 1268, SB 1302, SB 856, SB 650, SB 583, SB 673, SB 840, SB 213, SB 681, SB 1172, SB 1252, SB 378, SB 610, SB 918, SB 1343, SB 608, SB 487, SB 955, SB 957, SB 988, SB 990, SB 1019, SB 1021, SB 1120, SB 251, SB 958, SB 535, SB 761, SB 1, SB 541, SB 315, SB 379, SB 1018, SB 1737, SB 266, SB 1415, SB 57, SB 499, SB 974, SB 1025, SB 1061, SB 1268, SR 302, SR 303, SR 304, SR 305, SB 30, SB 1333, SB 1666, SB 30, SB 1333, SB 1666

Keywords: water rights, treaty compliance, Rio Grande, agriculture, drought, international water, Texas water supply, Texas, Israel, trade, investment, partnership, economic ties, technological innovation, bilateral relations, appropriations, budget, state funding, education, healthcare

Transcript Highlights:

• Genetics are part of the picture in understanding Parkinson's, but environmental exposures play a significant
• And none of us have a genetic link to the Parkinson's.
• And none of us have<00:30:07.600> a<00:30:07.840> genetic<00:30:08.320> link<00:
• have a genetic link to the Parkinson's. have a genetic link to the Parkinson's.

Keywords: 919, house, all

Summary: The meeting focused on two Parkinson’s-related bills in Minnesota: one to ban paraquat and another to create a state Parkinson’s research trust fund. Rep. Christy Purcell said the research bill would create a dedicated pot of money to coordinate and fund Parkinson’s research in Minnesota, with Sen. Mann as the Senate author. Supporters said Minnesota should act because Parkinson’s is growing rapidly, there is no cure, and state institutions could serve as a research hub. Several people living with Parkinson’s testified about the personal and family impact of the disease, including early-onset diagnoses, loss of work, mobility challenges, and the burden on caregivers. Speakers from the Parkinson’s Foundation and the Michael J. Fox Foundation supported both bills, arguing that paraquat is strongly linked to Parkinson’s, that exposure can affect farmers and nearby residents, and that prevention and research are both needed. The paraquat bill was described as especially important because alternatives exist and the chemical is reportedly used very little in Minnesota. During the discussion, Rep. Hansen said the paraquat bill would be held over and not voted on that day because a fiscal note was requested. He said the committee would hear the bill later that day and urged colleagues to keep an open mind. In response to questions, supporters said they anticipated little opposition beyond chemical-industry interests, and they emphasized that the bill was aimed specifically at paraquat rather than other chemicals. The research bill was discussed as a possible $25 million request, though no vote was taken on that proposal in the transcript.

Transcript Highlights:

• Procedures that can fail to consider infants and young children with pre-existing genetic conditions.
• The bill ensures that children with pre-existing genetic conditions are not are only separated from their
• And in Florida, children with pre-existing genetic condition such as rickets Ehlers-Danlos syndrome Osteogenesis
• during pregnancy or childbirth to stop premature devote delivery and it says Abate these couldn't genetic
• However, genetic DNA testing, which is critical and identify a pre-existing conditions can take 3 to

Keywords: 999, senate, all

Transcript Highlights:

• For those of you who don't know, sickle cell is a genetic condition that causes some of an infected person's
• this information, because you've just laid out the reason. why this is problematic, you've got a genetic
• A genetic charge, a genetic disease that affects so many, but do we really have our arms?

Bills: HB 118, HB388, HB 114, HB205, HB2789, HB2791, HB499, HB2960, HB3163, HB3135, HB2427, HB1618, HB1672, HB1722, HB1338, HB787, HB2618, HB879, HB 1126, HB4134, HB3513, HB718, HB1536, HB1445, HB1640, HB1893, HB1734, HB3229, HB3306, HB 1276, HB3272, HB3276, HB3516, HB4145, HB1585, HB4810, HB2989, HB2558, HB3014, HB2742, HB1695, HB29, HB 125, HB145, HB171, HB255, HB50, HB363, HB 116, HB491, HB1495, HB368, HB 1285, HB1905, HB2002, HB917, HB2723, HB2067, HB 1238, HB745, HB 1188, HB1606, HB2003, HB2147, HB2355, HB2546, HB2495, HB2818, HB2249, HB3228, HB3240, HB1507, HB658, HB1748, HB1851, HB1922, HB2798, HB 107, HB1587, HB3684, HB 118, HB388, HB 114, HB205, HB2789, HB2791, HB499, HB2960, HB3163, HB3135, HB2427, HB1618, HB1672, HB1722, HB1338, HB787, HB2618, HB879, HB 1126, HB4134, HB3513, HB718, HB1536, HB1445, HB1640, HB1893, HB1734, HB3229, HB3306, HB 1276, HB3272, HB3276, HB3516, HB4145, HB1585, HB4810, HB2989, HB2558, HB3014, HB2742, HB1695, HB609, HB630, HB420, HB767, HB1708, HB1404, HB2457, HB140, HB227, HB913, HB2198, HB2763, HB 1261, HB 1135, HB1318, HB2358, HB2765, HB2735, HB3307, HB 1242, HB2842, HB333, HB201, HB694, HB2415, HB155, HB272, HB405, HB519, HB 1136, HB 1275, HB1437, HB1532, HB1675, HB1868, HB1888, HB1990, HB2286, HB2523, HB3129, HB3251, HB3354, HB3479, HB3803, HB3804, HB3805, HB3806, HB3887, HB4163, HB4238, HB 1240, HB1842, HB2029, HB2622, HB3255, HB654, HB4643, HB4945, HB3611, HB3724, HB3623, HB3810, HB4127, HCR78, HCR12, SB767

Keywords: HB 388, HB388, coordination of benefits, COB questionnaire, health benefit plan, health insurance, insurance commissioner, Texas Department of Insurance, uniform form, primary payer, secondary payer, multiple coverage, dual coverage, Medicaid, CHIP, managed care, HMO, small employer health plan, school district health coverage, self-funded plan

Transcript Highlights:

• There is also evidence suggesting potential integration of the vaccine-derived genetic material into
• cellular... ...derived genetic material into cellular DNA.
• which that is supposed to work, but there is some concern when it is... when they find that this genetic

Keywords: 928, house, all

Summary: The Special Committee on COVID Response Efficacy met to review its mission, approve prior minutes at a future meeting, and discuss materials related to COVID-19 vaccination guidance. Members examined a pediatric vaccination handout from a private pediatric practice and compared it with New Hampshire DHHS and AAP/AAFP immunization guidance, focusing on how COVID-19 vaccine recommendations are presented for children and adults. Committee members also discussed the scope and accuracy of the committee’s endnotes and supporting documents. The main business was a draft letter urging the governor to direct state agencies to stop recommending COVID-19 mRNA vaccines. Members revised the letter paragraph by paragraph, including changing wording about age ranges for children, clarifying references to the American Academy of Pediatrics, and adding discussion of vaccine safety concerns, alleged suppression of safety data, and federal investigations. They also debated whether to reference specific reporting systems such as VAERS and V-safe, and whether to include examples from other states, including Tennessee, Arizona, Minnesota, and Florida, as evidence of broader concern about mRNA vaccines. After the edits were completed, Representative Villio moved to accept the letter as amended, Representative Leroy seconded, and the committee approved it by voice vote 4-0. The chair said the revised letter would be finalized and distributed later in the week. The meeting then adjourned at approximately 11:57 a.m.